June 9, 2025 - 01:17

Starting this week, residents in London, Manchester, Birmingham, Cardiff, Belfast, and Glasgow will have the opportunity to utilize a groundbreaking eye-scanning identification technology. This innovative system, developed by Tools for Humanity, employs a proprietary orb device that allows individuals to scan their eyes for secure identification.
The expansion into the UK marks a significant milestone for the technology, which aims to streamline verification processes in various sectors, including finance, travel, and security. Users will benefit from enhanced convenience and safety, as the eye-scanning method provides a quick and reliable way to confirm identity without the need for traditional identification documents.
As cities prepare for the rollout, officials emphasize the importance of privacy and data security, reassuring the public that their biometric information will be handled with the utmost care. The introduction of this technology is expected to transform how identification is approached, paving the way for a more efficient and secure future.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...